DK155174C - Fremgangsmaade til fremstilling af et terapeutisk immunosuppressivt middel - Google Patents

Fremgangsmaade til fremstilling af et terapeutisk immunosuppressivt middel

Info

Publication number
DK155174C
DK155174C DK049178A DK49178A DK155174C DK 155174 C DK155174 C DK 155174C DK 049178 A DK049178 A DK 049178A DK 49178 A DK49178 A DK 49178A DK 155174 C DK155174 C DK 155174C
Authority
DK
Denmark
Prior art keywords
procedure
preparation
immunosuppressive agent
therapeutic immunosuppressive
therapeutic
Prior art date
Application number
DK049178A
Other languages
English (en)
Other versions
DK155174B (da
DK49178A (da
Inventor
David Harvey Katz
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK49178A publication Critical patent/DK49178A/da
Publication of DK155174B publication Critical patent/DK155174B/da
Application granted granted Critical
Publication of DK155174C publication Critical patent/DK155174C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S524/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S524/90—Antigen-antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
DK049178A 1977-02-03 1978-02-02 Fremgangsmaade til fremstilling af et terapeutisk immunosuppressivt middel DK155174C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76458677 1977-02-03
US05/764,586 US4191668A (en) 1977-02-03 1977-02-03 Induction of immunological tolerance

Publications (3)

Publication Number Publication Date
DK49178A DK49178A (da) 1978-08-04
DK155174B DK155174B (da) 1989-02-27
DK155174C true DK155174C (da) 1989-07-10

Family

ID=25071153

Family Applications (1)

Application Number Title Priority Date Filing Date
DK049178A DK155174C (da) 1977-02-03 1978-02-02 Fremgangsmaade til fremstilling af et terapeutisk immunosuppressivt middel

Country Status (17)

Country Link
US (1) US4191668A (da)
JP (1) JPS53121943A (da)
AU (1) AU515181B2 (da)
BE (1) BE863656A (da)
CA (1) CA1118347A (da)
CH (1) CH644521A5 (da)
DE (1) DE2804457C2 (da)
DK (1) DK155174C (da)
FI (1) FI780312A (da)
FR (1) FR2379287A1 (da)
GB (1) GB1599454A (da)
LU (1) LU78997A1 (da)
MX (1) MX6266E (da)
NL (1) NL7801220A (da)
NO (1) NO153419C (da)
SE (1) SE464616B (da)
ZA (1) ZA78613B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4276206A (en) * 1979-01-18 1981-06-30 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4253995A (en) * 1980-02-11 1981-03-03 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
US4253996A (en) * 1980-02-13 1981-03-03 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
DE3114362C2 (de) * 1980-04-11 1983-08-18 Toshiyuki Prof. Nara Hamaoka Verfahren zur Herstellung eines Antikörpers bzw. Antiserums, Verwendung dieses Verfahrens zur Gewinnung von Säugetierzellen, welche fähig sind, einen solchen Antikörper zu erzeugen und Verwendung des so hergestellten Antikörpers bzw. Antiserums zur Immunoprüfung
EP0077158A1 (en) * 1981-10-09 1983-04-20 Beecham Group Plc Modified allergens
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5126131A (en) * 1983-01-24 1992-06-30 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates.
US6022544A (en) * 1983-01-24 2000-02-08 The John Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
CA1309558C (en) * 1986-05-30 1992-10-27 Quidel D-gl conjugate therapy
US4950469A (en) * 1986-05-30 1990-08-21 La Jolla Pharmaceutical Company D-GL conjugate therapy
US4950713A (en) * 1986-05-30 1990-08-21 La Jolla Pharmaceutical Company Conjugates of D-glutamic acid: D-lysine copolymer and certain biochemicals
US5017648A (en) * 1986-05-30 1991-05-21 La Jolla Pharmaceutical Company D-GL conjugate therapy
US5268454A (en) * 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
US5391785A (en) * 1990-01-16 1995-02-21 La Jolla Pharmaceutial Company Intermediates for providing functional groups on the 5' end of oligonucleotides
US5162515A (en) * 1990-01-16 1992-11-10 La Jolla Pharmaceutical Company Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus
US5552391A (en) * 1990-01-16 1996-09-03 La Jolla Pharmaceutical Company Chemically-defined non-polymeric valency platform molecules and conjugates thereof
CA2073846C (en) * 1991-07-15 2007-09-18 David S. Jones Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US8071737B2 (en) 1995-05-04 2011-12-06 Glead Sciences, Inc. Nucleic acid ligand complexes
US6410775B1 (en) * 1995-06-07 2002-06-25 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US5874409A (en) 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
US6458953B1 (en) * 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
US6399578B1 (en) * 1998-12-09 2002-06-04 La Jolla Pharmaceutical Company Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
US20030039659A1 (en) * 1999-09-24 2003-02-27 Mccormick Alison A. Self antigen vaccines for treating B cell lymphomas and other cancers
US7084256B2 (en) * 1999-09-24 2006-08-01 Large Scale Biology Corporation Self antigen vaccines for treating B cell lymphomas and other cancers
CA2414076A1 (en) 2000-06-08 2001-12-13 La Jolla Pharmaceutical Company Multivalent platform molecules comprising high molecular weight polyethylene oxide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1282163A (en) * 1969-08-06 1972-07-19 Beecham Group Ltd Modified allergens and a process for their preparation
US3825525A (en) * 1969-08-06 1974-07-23 Beecham Group Ltd Allergens reacted with carbodiimides

Also Published As

Publication number Publication date
FI780312A (fi) 1978-08-04
JPS53121943A (en) 1978-10-24
GB1599454A (en) 1981-10-07
LU78997A1 (fr) 1978-06-21
FR2379287B1 (da) 1980-08-29
AU515181B2 (en) 1981-03-19
SE464616B (sv) 1991-05-27
JPH0428689B2 (da) 1992-05-15
NL7801220A (nl) 1978-08-07
CA1118347A (en) 1982-02-16
FR2379287A1 (fr) 1978-09-01
DK155174B (da) 1989-02-27
DK49178A (da) 1978-08-04
US4191668A (en) 1980-03-04
DE2804457C2 (de) 1984-04-12
MX6266E (es) 1985-02-27
AU3293378A (en) 1979-08-09
DE2804457A1 (de) 1978-08-10
BE863656A (fr) 1978-05-29
NO780366L (no) 1978-08-04
NO153419B (no) 1985-12-09
NO153419C (no) 1986-03-19
SE7801268L (sv) 1978-08-04
ZA78613B (en) 1978-12-27
CH644521A5 (de) 1984-08-15

Similar Documents

Publication Publication Date Title
DK155174C (da) Fremgangsmaade til fremstilling af et terapeutisk immunosuppressivt middel
DK151931C (da) Fremgangsmaade til fremstilling af et farmacentisk praeparat i enhedsdosisform
DK536178A (da) Fremgangsmaade til fremstilling af stilbenderivater
DK110778A (da) Fremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer
DK306978A (da) Fremgangsmaade til fremstilling af 1-acyl-2-cyanaziridiner
DK569678A (da) Fremgangsmaade til fremstilling af 2alfa-cyano-3-oxosteroider
DK484677A (da) Fremgangsmaade til fremstilling af furokumariner
DK145701C (da) Fremgangsmaade til fremstilling af ergotalkaloider
DK466878A (da) Fremgangsmaade til fremstilling af 0-methallyloxyphenol
DK237978A (da) Fremgangsmaade til fremstilling af alfafluormethyl-alfa-aminoalkansyrer
DK352578A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat
DK154949C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK436978A (da) Fremgangsmaade til fremstilling af sarcosinoxidase
DK577078A (da) Fremgangsmaade til fremstilling af trans-4a-aryloctahydro-1h-2-pyridiner
DK5778A (da) Femgangsmaade til fremstilling af 4-diphenylmethylen-1-hydroxybenzyl-piperidiner
DK50878A (da) Fremgangsmaade til fremstilling af oxadiazolopyrimidinderivater
DK295378A (da) Fremgangsmaade til fremstilling af terapeutisk virksomme diarylalkylaminer
DK364578A (da) Fremgangsmaade til fremstilling af hydroxyphenylhydantoin
DK529278A (da) Fremgangsmaade til fremstilling af farmaceutisk virksomme thiolestere
DK248978A (da) Fremgangsmaade til fremstilling af hydroxy-alfa-aminobenzylpenicillin
DK246878A (da) Fremgangsmaade til fremstilling af acylderivater
DK339777A (da) Fremgangsmaade til fremstilling af 2-benzylperhydroazepiner
DK383978A (da) Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidin-4-oner
DK441878A (da) Fremgangsmaade til fremstilling af bibenzylderivater
DK28078A (da) Fremgangsmaade til fremstilling af et tetraalkylthiuramdisulfid

Legal Events

Date Code Title Description
PBP Patent lapsed